Prognostic value of bleeding after percutaneous coronary intervention in patients with diabetes. [electronic resource]
Producer: 20150105Description: 83-9 p. digitalISSN:- 1969-6213
- Abciximab
- Aged
- Antibodies, Monoclonal -- adverse effects
- Anticoagulants -- adverse effects
- Antithrombins -- adverse effects
- Aspirin -- adverse effects
- Clopidogrel
- Coronary Artery Disease -- complications
- Diabetes Mellitus, Type 2 -- complications
- Female
- Hemorrhage -- chemically induced
- Heparin -- adverse effects
- Hirudins -- adverse effects
- Humans
- Immunoglobulin Fab Fragments -- adverse effects
- Logistic Models
- Male
- Middle Aged
- Peptide Fragments -- adverse effects
- Percutaneous Coronary Intervention
- Platelet Aggregation Inhibitors -- adverse effects
- Prognosis
- Proportional Hazards Models
- Recombinant Proteins -- adverse effects
- Risk Factors
- Stents
- Ticlopidine -- adverse effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.